Page last updated: 2024-09-05

sorafenib and berberine

sorafenib has been researched along with berberine in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(berberine)
Trials
(berberine)
Recent Studies (post-2010) (berberine)
6,5207305,2514,1061022,791

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)berberine (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.7827
Lysine-specific histone demethylase 1AHomo sapiens (human)6.97
CholinesteraseHomo sapiens (human)1.09
AcetylcholinesteraseHomo sapiens (human)0.4
Aldo-keto reductase family 1 member C3Homo sapiens (human)4.99
Aldo-keto reductase family 1 member C2 Homo sapiens (human)6.71
CholinesteraseEquus caballus (horse)9.4
Cytochrome P450 1B1Homo sapiens (human)0.9747

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gu, C; Huang, Y; Liu, S; Mai, W; Nie, Y; Wang, K; Yang, H; Yu, G; Zhao, D; Zhong, Y1

Other Studies

1 other study(ies) available for sorafenib and berberine

ArticleYear
Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib.
    Oncology reports, 2018, Volume: 40, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Berberine; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Sorafenib; Tumor Cells, Cultured

2018